A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：PHARMACOECONOMICS ISSN： 1170-7690 版本： SCI-CDE 出版频率： Monthly 出版社： ADIS INT LTD, 5 THE WAREHOUSE WAY, NORTHCOTE, NEW ZEALAND, AUCKLAND, 0627   出版社网址： http://www.adis.com/ 期刊网址： http://adisonline.com/pharmacoeconomics/pages/default.aspx 影响因子： 4.981 主题范畴： HEALTH CARE SCIENCES & SERVICES;    PHARMACOLOGY & PHARMACY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal PharmacoEconomics PharmacoEconomics is the benchmark journal for peer reviewed authoritative and practical articles on the application of pharmacoeconomics, outcomes research and quality of life assessment to optimum drug therapy and health outcomes. An invaluable source of pharmacoeconomic research and methodology, PharmacoEconomics provides you with clear communications of complex pharmacoeconomic issues related to patient care and drug utilisation, providing the basis for informed clinical prescribing decisions and allocation of healthcare resources. PharmacoEconomics articles take into account the needs of key groups in this discipline, making it essential reading for:   Formulary Managers   Healthcare Providers & Institutions   Healthcare Policy & Decision Makers   Executives in Managed Care and Health Maintenance Organisations   Employers and Other Healthcare Payors   Executives in Pharmaceutical Companies Pharmacoeconomic Academics  PharmacoEconomics promotes the continuing development and study of pharmacoeconomics, outcomes research and quality-of-life assesment as applied to optimum drug therapy and health outcomes. The journal provides a practical economic background to informed clinical prescribing decisions and allocation of healthcare resources. Instructions to Authors   Submission of original research to all International Review Journals with the exception of Drugs is encouraged. Suggestions for article topics (and potential authors) for consideration by the editors and editorial boards are welcome at any time. If you are interested in preparing a review, please contact the journal with your proposed outline to confirm suitability. You should also review the policy statements for review articles and original research and Adis Drug Evaluations and Adis Drug Profiles. The following PDF documents contain instructions and information for the preparation and layout of documents for submission. Original Research All Adis International Review Journals, aside from Drugs, consider Original Research Articles for publication. Please refer to the Instructions for Authors of the specific journal you are interested in to determine the desired article types.   Current Opinion   A Current Opinion article should be a succinct commentary on the topic proposed, not an exhaustive review. The overall objective is to place in perspective an area of current international interest that may be controversial, and for this reason personal opinion, clearly identified as such, is welcome. The arguments presented may be controversial, but at the same time must be balanced and rational. In addition, the article should be of international scope.   Therapy in Practice The intention of a Therapy in Practice article is to provide a succinct, clinically orientated guide to management of a particular disease or condition. The article need not be heavily referenced, although important points and definitive statements should be supported by appropriate literature citations. There is room for some personal opinion if it is clearly identified as such. However, the internationally accepted consensus on appropriate therapeutic guidelines should be the aim. Leading Article  A Leading Article should be a short, balanced review of a relatively small literature base, typically of a new or developing topic, that should provide an overview of the current state of development of the area being written about. The article should be fully referenced and of international scope.   Review Article  The Review Article should be an authoritative, comprehensive and critical review of the literature, reflecting the current state of accepted international medical practice or clinical research in a particular area. The article must present a balanced, rather than personal, review of the literature, and should be fully referenced. Wherever possible, literature should be evaluated rather than simply restated. Furthermore, all therapies of relevance to the topic should be discussed in order to provide full coverage of the spectrum of agents used in the disease area or drug category under discussion. Reference Style Guide References are required to support all significant statements. They are also used to indicate the origin of material (quotations, tables, figures), and as a source for research and further reading. They need to be given in a form where the reader can quickly and easily identify the correct reference and locate the material in a library or on a database. Our referencing system is based on the 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals' (the 'Vancouver' style), with some minor modifications. It is important to adhere to the style set out here (e.g. superior numbers inside square brackets in the text), which will facilitate processing. Editorial Board Consulting Editor:  J.A. Paladino, Buffalo, NY, USA A.H. Anis, Vancouver, BC, Canada F. Antonanzas, Logron o, Spain X. Badia, Barcelona, Spain H. Birnbaum, Boston, MA, USA B.S. Bloom, Philadelphia, PA, USA J.L. Bootman, Tucson, AZ, USA C.J. Bulpitt, London, England K.M. Bungay, Boston, MA, USA A. Chockalingam, Orleans, ON, Canada P.G. Davey, Dundee, Scotland C. Destache, Omaha, NE, USA M.F. Drummond, York, England D. Feeny, Edmonton, AB, Canada N. Freemantle, Birmingham, England D.A. Freund, Syracuse, NY, USA S. Garattini, Milan, Italy F. Gevirtz, Morrisville, NC, USA P. Greenberg, Boston, MA, USA S. Hill, Waratah, NSW, Australia N. Ikegami, Tokyo, Japan B. Jönsson, Stockholm, Sweden I. Kamae, Kobe, Japan B.R. Luce, Bethesda, MD, USA C. Lucioni, Milan, Italy A. Maynard, London, England W.F. McGhan, Philadelphia, PA, USA P.S. McKinnon, Detroit, MI, USA P. Meek, Madison, WI, USA R.J. Milne, Auckland, New Zealand C.D. Mullins, Baltimore, MD, USA D.B. Nash, Philadelphia, PA, USA M.S. Niederman, Long Island, NY, USA S. Nishimura, Kyoto, Japan S.R. Norrby, Lund, Sweden B.J. O'Brien, Hamilton, ON, Canada J. Rovira, Barcelona, Spain F.F.H. Rutten, Rotterdam, The Netherlands L.A. Sanchez, Highlands Ranch, CO, USA G.T. Schumock, Chicago, Ill, USA D.A. Sclar, Pullman, WA, USA T.A. Sheldon, York, England S.R. Shulman, Buffalo, NY, USA S.D. Sullivan, Seattle, WA, USA T.D. Szucs, Zurich, Switzerland G.W. Torrance, Hamilton, ON, Canada J. Urquhart, Palo Alto, CA, USA B.A. van Hout, Rotterdam, The Netherlands R.E. Vestal, Boise, ID, USA